Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Wassim Abida, David Campbell, Akash Patnaik, Alan H. Bryce, Jeremy Shapiro, Richard Bambury, Jingsong Zhang, John M. Burke, Daniel Castellano, Albert Font, Vinod Ganju, Anne‐Claire Hardy‐Bessard, Ray McDermott, Brieuc Sautois, Dominique Spaëth, Éric Voog, Josep M. Piulats, Elias Pintus, Charles J. Ryan, Axel S. Merseburger, Gedske Daugaard, Axel Heidenreich, Karim Fizazi, Andrea Loehr, Darrin Despain, Andrew D. Simmons, Melanie Dowson, Jowell Go, Simon P. Watkins, Simon Chowdhury
Topics & Concepts
MedicineProstate cancerDNA repairOncologyGeneDNA damageInternal medicineProstateCancer researchDNACancerGeneticsBiologyProstate Cancer Treatment and ResearchPARP inhibition in cancer therapyProstate Cancer Diagnosis and Treatment